Accuri Cytometers

Accuri Cytometers

Founded 2004

Ann Arbor, United States 9 employees Series E Total: $32.66M Biotechnology, Health Care +2

Accuri Cytometers is a biotechnology startup founded in 2004 and headquartered in the United States. The company was acquired by BD and is now a wholly owned subsidiary. Accuri Cytometers addresses a critical need in the life sciences field, aiming to make flow cytometry more accessible to researchers. The startup recognizes the challenges researchers face, such as the high cost of instruments, software complexity, maintenance efforts, and space requirements. To tackle these issues, Accuri Cytometers has focused on creating an affordable, robust, and easy-to-use flow cytometer. The company's innovative approach is reflected in its engineering team, which has executed a ground-up design of a new instrument tailored to meet customer-driven specifications. Accuri Cytometers received a significant $6.00M Series E investment on 19 October 2010, with participation from notable investors including Arboretum Ventures, Baird Capital, F-Prime Capital, Flagship Pioneering, and InvestMichigan. This investment is a testament to the confidence these prominent investors have in the potential of Accuri Cytometers' innovative solution in the biotechnology, healthcare, and manufacturing industries.

Funding Stage	Amount	Investors	Lead Investors	Date
Series E	$6.00M	5	Arboretum Ventures, Baird Capital +3	19 Oct 2010
Series D	$4.00M	6	Arboretum Ventures, Baird Capital +4	10 Aug 2009
Series C	$13.00M	3	Arboretum Ventures, Baird Capital +1	08 Jul 2008
Venture Round	$2.00M	1	Eight Roads Ventures	29 Apr 2008
Series B	$100.00K	-		01 Sep 2007
Series B	$5.00M	2	Arboretum Ventures, Baird Capital	30 Apr 2007
Venture Round	$1.75M	-		01 Sep 2005
Series A	$805.00K	7	Plymouth Growth, Arboretum Ventures +5	01 Mar 2005

Funding Stage

Amount

Investors

Lead Investors

Date

Series E

$6.00M

Arboretum Ventures, Baird Capital +3

19 Oct 2010

Series D

$4.00M

Arboretum Ventures, Baird Capital +4

10 Aug 2009

Series C

$13.00M

Arboretum Ventures, Baird Capital +1

08 Jul 2008

Venture Round

$2.00M

Eight Roads Ventures

29 Apr 2008

Series B

$100.00K

01 Sep 2007

Series B

$5.00M

Arboretum Ventures, Baird Capital

30 Apr 2007

Venture Round

$1.75M

01 Sep 2005

Series A

$805.00K

Plymouth Growth, Arboretum Ventures +5

01 Mar 2005

FAQ About Accuri Cytometers

Now a wholly owned subsidiary of BD, Accuri Cytometers, Inc. was founded to address a compelling need: life scientists love the rapid cell-by-cell analysis capability of flow cytometers, but too few have a flow cytometer in their lab. The barriers for most researchers include cost of the instrument,...

Accuri Cytometers was founded in 2004.

Accuri Cytometers is headquartered in Ann Arbor, United States.

Accuri Cytometers operates in Biotechnology, Health Care, Manufacturing and Medical Devices. Its work centres on Flow cytometry, Life science, Cell analysis and Instrumentation.

Accuri Cytometers has approximately 9 employees.

Accuri Cytometers has completed 8 funding rounds, raising a total of $32.66M. The latest funding stage is Series E.

Top alternatives and competitors to Accuri Cytometers include Durviz, S. L., 艾力特国际贸易有限公司, Guava Technologies, BI Biotech India Pvt. Ltd., Cyntellect. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Accuri Cytometers and Durviz, S. L. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About Accuri Cytometers

Funding Rounds & Investors (8)

Accuri Cytometers Alternatives & Competitors

FAQ About Accuri Cytometers